Influence of Low Energy Availability on Skeletal Muscle and Cardiovascular Health (LEA)

November 16, 2022 updated by: University of Aarhus

Influence of Low Energy Availability on Performance and Health in Trained and Recreationally Active Women

The project is designed as a randomized controlled intervention trial in which 60 young trained (n = 30) (Population A) and recreationally active (n = 30) women (Population B) with regular menstruation are divided into four groups. Population A will receive a low-calorie diet + exercise or an energy balanced diet + exercise over 10 days. Population B will receive a low-calorie diet without exercise, or an energy balanced diet over 10 days. The participants are matched in pairs based on training history and randomized. Before the diet period, the groups will undergo a 6-day control period, during which all participants must take an energy-balanced diet (± training). After the 10 days of the diet intervention period, the groups will receive an energy-balanced diet for 2 days. Before, during, and after the trial period, participants will perform performance tests. In addition, 3 muscle biopsies, 2 adipose biopsies, blood samples, urine samples will be taken during the period, as well as resting metabolic rate, electrocardiogram, flow-mediated vasodilation, and body composition over the trial period. Muscle protein synthesis rate will be measured over the period using stable isotope technique, which includes ingestion of heavy water (D2O) and collection of saliva samples daily (days 0 to 16). The primary measurement parameter is changes in muscle protein synthesis rate.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, 8000
        • Recruiting
        • Aarhus University, Department for Public Health, Section for Sport Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • age 18-30
  • BMI 18.5-30
  • Regular training at least 4 times a week and a maximum of 10 times a week (≥1 times strength training, ≥1 times endurance training / interval training or interval-based sports

Exclusion Criteria:

  • • Irregular menstruation within the last 6 months (shorter end 24 days or longer end 35 days cycle)

    • Used hormonal contraception within the last 3 months for the trial.
    • Injuries / pain in the lower body, which prevents participation in intense strength training
    • Medication consumption that may affect protein metabolism and inflammatory parameters.
    • Diabetes
    • Smoking
    • Unstable weight / major weight loss (weight fluctuations of more than 5 kg in the last six months)
    • Do not eat animal products
    • Eating disorder
    • Pregnancy
    • Blood donor within the last month
    • Cannot read or understand Danish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Energy balance
Energy balance is set to 50 kcal / kg fat-free mass
EXPERIMENTAL: Energy restriction
Energy restriction is set to 25 kcal / kg fat-free mass
ACTIVE_COMPARATOR: Energy balance + exercise
Energy balance is set to 50 kcal / kg fat-free mass
Exercise will consist of supervised resistance training, interval training and moderate intensity cycling
EXPERIMENTAL: Energy restriction + exercise
Energy restriction is set to 25 kcal / kg fat-free mass
Exercise will consist of supervised resistance training, interval training and moderate intensity cycling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in muscle protein synthesis
Time Frame: 10 days of diet+exercise intervention
10 days of diet+exercise intervention

Secondary Outcome Measures

Outcome Measure
Time Frame
Markers of muscle protein synthesis and breakdown
Time Frame: before and after 10 days of diet+exercise intervention
before and after 10 days of diet+exercise intervention
Muscle glycogen and lipid levels
Time Frame: before and after 10 days of diet+exercise intervention
before and after 10 days of diet+exercise intervention
Sarcoplasmic reticulum function
Time Frame: before and after 10 days of diet+exercise intervention
before and after 10 days of diet+exercise intervention
Macrophage content in adipose tissue
Time Frame: before and after 10 days of diet+exercise intervention
before and after 10 days of diet+exercise intervention
Adipocyte area and cell size in adipose tissue
Time Frame: before and after 10 days of diet+exercise intervention
before and after 10 days of diet+exercise intervention
Expression of fat oxidative proteins in adipose tissue
Time Frame: before and after 10 days of diet+exercise intervention
before and after 10 days of diet+exercise intervention
Maximal isometric and dynamic muscle strength
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance
Maximal vertical jump height
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance
Repeated sprint ability
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance
4-minute time trial performance
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance
Sex hormone levels
Time Frame: During the course of the whole intervention period (18 days)
During the course of the whole intervention period (18 days)
Cortisol Levels
Time Frame: During the course of the whole intervention period (18 days)
During the course of the whole intervention period (18 days)
Inflammatory levels
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance
Bone turnover levels
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance
Electrocardiogram - Qt interval
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance
Flow mediated vasodilation
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance
Resting metabolic rate
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance
Body composition
Time Frame: before and after 10 days of diet+exercise intervention and 2 days of energybalance
before and after 10 days of diet+exercise intervention and 2 days of energybalance

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 1, 2021

Primary Completion (ACTUAL)

July 1, 2022

Study Completion (ANTICIPATED)

December 1, 2024

Study Registration Dates

First Submitted

March 24, 2021

First Submitted That Met QC Criteria

March 26, 2021

First Posted (ACTUAL)

March 29, 2021

Study Record Updates

Last Update Posted (ACTUAL)

November 17, 2022

Last Update Submitted That Met QC Criteria

November 16, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LEA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diet; Deficiency

Clinical Trials on Diet intervention - Energy balance

3
Subscribe